Evidence map›Paper›PMID 33765683›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2021

HIV Incidence by Male Circumcision Status From the Population-Based HIV Impact Assessment Surveys-Eight Sub-Saharan African Countries, 2015-2017.

Jonas Z Hines, Karampreet Sachathep, Sherri Pals, Stephanie M Davis, Carlos Toledo, Megan Bronson, Bharat Parekh, Maria Carrasco, Sinokuthemba Xaba, John Mandisarisa and 20 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04117984 (Swaziland HIV Incidence Measurement Survey), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04117984 completednot on this map

Swaziland HIV Incidence Measurement Survey (SHIMS 2, 2016): a Population-based HIV Impact Assessment (PHIA)

TypeobservationalSponsorColumbia UniversityRan2016 to 2019Enrolled15,429ConditionsHIV/AIDS
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. HIV prevention in Africa: is VMMC useful and acceptable?International journal of impotence research · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 15 institutions in 9 countries.

Jonas Z HinesDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
Karampreet SachathepICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, New York.
Sherri PalsDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
Stephanie M DavisDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
Carlos ToledoDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
Megan BronsonDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
Bharat ParekhDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
Maria CarrascoOffice of HIV and AIDS, U.S. Agency for International Development, Washington, District of Columbia.
Sinokuthemba XabaMinistry of Health and Child Care, Harare, Zimbabwe.
John MandisarisaDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Harare, Zimbabwe.
Royd KamobyiMinistry of Health, Lusaka, Zambia.
Omega ChituwoDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Lusaka, Zambia.
Wilford L KirungiMinistry of Health, Kampala, Uganda.
Stella AlamoDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Kampala, Uganda.
Geoffrey KabuyeDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Kampala, Uganda.
Anna Colletar AworDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Kampala, Uganda.
Susan MmbandoNational AIDS Control Programme, Ministry of Health, Community Development, Gender, Elderly and Children, Dar es Salaam, Tanzania.
Daimon SimbeyeDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Mekondjo A AupokoloNational HIV/AIDS, STI and Hepatitis Control Program, Ministry of Health and Social Services, Windhoek, Namibia.
Brigitte ZemburukaDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Windhoek, Namibia.
Rose NyirendaMinistry of Health, Lilongwe, Malawi.
Wezi MsungamaDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.
Tapiwa TarumbiswaMinistry of Health, Maseru, Lesotho.
Robert MandaU.S. Agency for International Development, Maseru, Lesotho.
Harriet Nuwagaba-BiribonwohaICAP at Columbia University, Mbabane, Eswatini.
Valerian KiggunduOffice of HIV and AIDS, U.S. Agency for International Development, Washington, District of Columbia.
Anne G ThomasDefense Health Agency, U.S. Department of Defense, San Diego, California; and.
Heather WattsOffice of Global AIDS Coordinator, Washington, District of Columbia.
Andrew C VoetschDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
Dan B WilliamsDivision of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
Centers for Disease Control and Prevention · USCenters for Disease Control and Prevention · UGUnited States Agency for International Development · USCentre for Infectious Disease Research in Zambia · ZMColumbia University · USDefense Health Agency · USEswatini Economic Policy Analysis and Research Centre · SZLesotho Planned Parenthood Association · LSMinistry of Health · MWMinistry of Health · UGMinistry of Health · LSMinistry of Health · ZMMinistry of Health and Child Welfare · ZWMinistry of Health and Social Services · NAMinistry of Health, Community Development, Gender, Elderly and Children · TZ

Funding

CGH CDC HHS U2G GH001226CGH CDC HHS U2G GH001271PEPFAR
6 · The paper itself

Abstract

backgroundMale circumcision (MC) offers men lifelong partial protection from heterosexually acquired HIV infection. The impact of MC on HIV incidence has not been quantified in nationally representative samples. Data from the population-based HIV impact assessments were used to compare HIV incidence by MC status in countries implementing voluntary medical MC (VMMC) programs.

methodsData were pooled from population-based HIV impact assessments conducted in Eswatini, Lesotho, Malawi, Namibia, Tanzania, Uganda, Zambia, and Zimbabwe from 2015 to 2017. Incidence was measured using a recent infection testing algorithm and analyzed by self-reported MC status distinguishing between medical and nonmedical MC. Country, marital status, urban setting, sexual risk behaviors, and mean population HIV viral load among women as an indicator of treatment scale-up were included in a random-effects logistic regression model using pooled survey weights. Analyses were age stratified (15-34 and 35-59 years). Annualized incidence rates and 95% confidence intervals (CIs) and incidence differences were calculated between medically circumcised and uncircumcised men.

resultsMen 15-34 years reporting medical MC had lower HIV incidence than uncircumcised men [0.04% (95% CI: 0.00% to 0.10%) versus 0.34% (95% CI: 0.10% to 0.57%), respectively; P value = 0.01]; whereas among men 35-59 years, there was no significant incidence difference [1.36% (95% CI: 0.32% to 2.39%) versus 0.55% (95% CI: 0.14% to 0.67%), respectively; P value = 0.14]. DISCUSSION: Medical MC was associated with lower HIV incidence in men aged 15-34 years in nationally representative surveys in Africa. These findings are consistent with the expected ongoing VMMC program impact and highlight the importance of VMMC for the HIV response in Africa.

Indexed as

Health SurveysHIV-1AdolescentAdultAfrica South of the SaharaCircumcision, MaleHIV InfectionsHumansIncidenceMaleRisk FactorsYoung Adult

Identifiers

PMID33765683
PMCPMC11187824
OpenAlexW3137238049

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.